Its the active ingredient in the type 2 diabetes drug Ozempic and the obesity treatment Wegovy, both taken as a weekly shot
Regression analysis of restricted mean survival time based on pseudo-observations
This is the conservative recommendation based on preservative effectiveness and peptide stability data
9 Reasons You're Not Getting the Best Results on GLP-1 Medications Progress slower on Wegovy or Mounjaro
Semaglutide, a medication approved for the treatment of type 2 diabetes, has also made waves in the realm of weight loss due to its efficacy in helping patients achieve significant weight reduction
As GLP-1 receptor agonists (GLP-1s) like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) become increasingly common in the treatment of diabetes, obesity, and cardiovascular disease, retina specialists are paying close attention to whether the drug therapies may influence ocular disease in already high-risk patients